Delayed breast cancer surgery in HER2 positive breast cancer

被引：0
|
作者：
Hur, Ho [1 ]
Le, Amy [2 ]
Chang, Helena R. [2 ]
机构：
[1] Yonsei Univ, Med Ctr, Seoul, South Korea
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Revlon UCLA Breast Ctr, Los Angeles, CA 90095 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P1-20-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-20-13
引用
收藏
页数：2
相关论文
共 50 条
  • [21] What therapies are on the horizon for HER2 positive breast cancer?
    Viale, Giulia
    Morganti, Stefania
    Ferraro, Emanuela
    Zagami, Paola
    Marra, Antonio
    Curigliano, Giuseppe
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (09) : 811 - 822
  • [22] THE UPFRONT THERAPY FOR HER2 POSITIVE BREAST CANCER PATIENTS
    Iwata, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
  • [23] Targeting HER2 Positive Breast Cancer with Chemopreventive Agents
    Wahler J.
    Suh N.
    Current Pharmacology Reports, 2015, 1 (5) : 324 - 335
  • [24] Immune Effects of Transtuzumab in HER2 Positive Breast Cancer
    Zgura, Anca
    Gales, Laurentia
    Haineala, Bogdan
    Bratila, Elvira
    Mehedintu, Claudia
    Barac, Ramona Ileana
    Berceanu, Costin
    Andreescu, Cristina Veronica
    Brinduse, Lacramioara Aurelia
    Ionescu, Alec
    Anghel, Rodica
    REVISTA DE CHIMIE, 2019, 70 (08): : 2791 - 2794
  • [25] Novel therapies for metastatic HER2 positive breast cancer
    Cossetti R.J.D.
    Gelmon K.A.
    Current Breast Cancer Reports, 2013, 5 (4) : 331 - 340
  • [26] Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations
    Kourie, Hampig Raphael
    Chaix, Marie
    Gombos, Andrea
    Aftimos, Phillippe
    Awada, Ahmad
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (08) : 947 - 957
  • [27] Testing for HER2 in breast cancer
    Lewis, F
    Jackson, P
    Lane, S
    Coast, G
    Hanby, AM
    HISTOPATHOLOGY, 2004, 45 (03) : 207 - 217
  • [28] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Irfan Cicin
    Hakan Karagol
    Ufuk Usta
    Atakan Sezer
    Sernaz Uzunoglu
    Rusen Alas-Cosar
    Tarkan Yetisyigit
    Kazim Uygun
    Medical Oncology, 2009, 26 : 335 - 343
  • [29] HER2 Signaling in Breast Cancer
    Shin, Incheol
    TRANSLATIONAL RESEARCH IN BREAST CANCER, 2021, 1187 : 53 - 79
  • [30] HER2 assessment in breast cancer
    Sapino, Anna
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S30 - S31
12345